64E-5.663. Training for the Parenteral Administration of Unsealed Radioactive Material Requiring a Written Directive  


Effective on Thursday, December 26, 2013
  • 1Except as provided in Rule 664E-5.657, 7F.A.C., the licensee shall require an authorized user for the parenteral administration requiring a written directive, to:

    24(1) Be an authorized user under Rule 3164E-5.660, 32F.A.C., for uses listed in sub-sub-subparagraph 3864E-5.660(2)(a)2.g.39(III) or 4164E-5.660(2)(a)2.g.42(IV), F.A.C., NRC or equivalent Agreement State requirements; or

    51(2) Be an authorized user under Rule 5864E-5.652 59or 6064E-5.655, 61F.A.C., NRC or equivalent Agreement State requirements and who meets the requirements in subsection 7564E-5.663(4), 76F.A.C. of this section; or

    81(3) Be certified by a medical specialty board whose certification process has been recognized by the NRC or an agreement state under Rule 10464E-5.652 105or 10664E-5.655, 107F.A.C., and who meets the requirements in subsection 11564E-5.663(4), 116F.A.C., of this section.

    120(4)(a) Have successfully completed 80 hours of classroom and laboratory training, applicable to parenteral administrations, for which a written directive is required, of any beta emitter, or any photon-emitting radionuclide with a photon energy less than 150 keV, and/or parenteral administration of any other radionuclide for which a written directive is required. The training must include the following:

    1781. Radiation physics and instrumentation;

    1832. Radiation protection;

    1863. Mathematics pertaining to the use and measurement of radioactivity;

    1964. Chemistry of radioactive material for medical use; and

    2055. Radiation biology; and

    209(b) Have work experience, under the supervision of an authorized user who meets the requirements in Rule 22664E-5.657, 22764E-5.660 228or 22964E-5.663, 230F.A.C., NRC or equivalent Agreement State requirements, in the parenteral administration, for which a written directive is required, of any beta emitter, or any photon-emitting radionuclide with a photon energy less than 150 keV, and/or parenteral administration of any other radionuclide for which a written directive is required. A supervising authorized user who meets the requirements in Rule 28864E-5.660, 289F.A.C., NRC or equivalent Agreement State requirements, must have experience in administering dosages as specified in sub-sub-subparagraph 30664E-5.660(2)(a)2.g.307(III) or 30964E-5.660(2)(a)2.g.310(IV), F.A.C., NRC or equivalent Agreement State requirements. The work experience must involve the following:

    3251. Ordering, receiving, and unpacking radioactive materials safely, and performing the related radiation surveys;

    3392. Performing quality control procedures on instruments used to determine the activity of dosages, and performing checks for proper operation of survey meters;

    3623. Calculating, measuring, and safely preparing patient or human research subject dosages;

    3744. Using administrative controls to prevent a medical event involving the use of unsealed radioactive material;

    3905. Using procedures to contain spilled radioactive material safely, and using proper decontamination procedures; and

    4056. Administering dosages to patients or human research subjects, that include at least 3 cases involving the parenteral administration, for which a written directive is required, of any beta emitter, or any photon-emitting radionuclide with a photon energy less than 150 keV and/or at least 3 cases involving the parenteral administration of any other radionuclide, for which a written directive is required; and

    468(c) Have obtained written attestation that the individual has satisfactorily completed the requirements in subsection 48364E-5.663(2) 484or 48564E-5.663(3), 486F.A.C., of this section, and have demonstrated the ability to function independently as an authorized user to fulfill the radiation safety related duties for a medical use licensee authorized for the parenteral administration of unsealed radioactive material requiring a written directive. Have obtained written attestation, signed by a preceptor authorized user or a residency program director who represents a consensus of residency program faculties (as long as at least one member of the residency program faculty is an authorized individual in the same category designated by the applicant seeking authorized status) who meets the requirements in Rule 58364E-5.657, 58464E-5.660 585or 58664E-5.663, 587F.A.C., NRC or equivalent Agreement State requirements. A preceptor authorized user, who meets the requirements in Rule 60464E-5.660, 605F.A.C., must have experience in administering dosages as specified in sub-sub-subparagraph 61664E-5.660(2)(a)2.g.617(III) or 61964E-5.660(2)(a)2.g.620(IV), F.A.C.

    622Rulemaking Authority 624404.051, 625404.061, 626404.071, 627404.081, 628404.141 FS. 630Law Implemented 632404.022, 633404.051(1), 634(4), (5), (6), (8), (9), (10), (11), 641404.061(2), 642(3), 643404.071(1), 644404.081, 645404.141 FS. 647History–New 2-11-10, Amended 12-26-13.

     

Rulemaking Events:

Historical Versions(1)

Select effective date to view different version.